OLADUNNI BOLADALE: Open Payments
NPI 1639743107 · BOLINGBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,032 in 50 payments from 14 companies in 2025. Trend: 2023 $14 · 2024 $1,531 · 2025 $2,032
Food & beverage: $2,032
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $569 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $416 |
| Axsome Therapeutics, Inc. | 5 | $238 |
| Tris Pharma Inc | 4 | $164 |
| Otsuka America Pharmaceutical, Inc. | 3 | $143 |
| Braeburn Inc. | 1 | $135 |
| Janssen Pharmaceuticals, Inc | 2 | $101 |
| Almatica Pharma LLC | 2 | $59 |
| Noven Therapeutics, LLC | 3 | $58 |
| Lundbeck LLC | 3 | $54 |
Products named: VRAYLAR, CAPLYTA, Auvelity, REXULTI, Dyanavel XR, BRIXADI, INVEGA SUSTENNA, LOREEV XR.
Industry payments across IL — which companies pay providers there.
